557 related articles for article (PubMed ID: 23262059)
21. Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.
Lucas AT; Price LS; Schorzman A; Zamboni WC
Nanomedicine (Lond); 2017 Aug; 12(16):2021-2042. PubMed ID: 28745129
[TBL] [Abstract][Full Text] [Related]
22. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
23. Advances in redox-responsive drug delivery systems of tumor microenvironment.
Guo X; Cheng Y; Zhao X; Luo Y; Chen J; Yuan WE
J Nanobiotechnology; 2018 Sep; 16(1):74. PubMed ID: 30243297
[TBL] [Abstract][Full Text] [Related]
24. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
Danhier F
J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
[TBL] [Abstract][Full Text] [Related]
25. Stimuli-responsive polymeric nanoparticles for nanomedicine.
Crucho CI
ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
[TBL] [Abstract][Full Text] [Related]
26. Self-Assembled Peptide-Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery.
Yan J; He W; Yan S; Niu F; Liu T; Ma B; Shao Y; Yan Y; Yang G; Lu W; Du Y; Lei B; Ma PX
ACS Nano; 2018 Feb; 12(2):2017-2026. PubMed ID: 29376322
[TBL] [Abstract][Full Text] [Related]
27. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticle systems reduce systemic toxicity in cancer treatment.
Wang H; Yu J; Lu X; He X
Nanomedicine (Lond); 2016 Jan; 11(2):103-6. PubMed ID: 26653177
[No Abstract] [Full Text] [Related]
30. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
32. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
33. Nuclear drug delivery for cancer chemotherapy.
Sui M; Liu W; Shen Y
J Control Release; 2011 Oct; 155(2):227-36. PubMed ID: 21846484
[TBL] [Abstract][Full Text] [Related]
34. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
35. Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives.
El-Sawy HS; Al-Abd AM; Ahmed TA; El-Say KM; Torchilin VP
ACS Nano; 2018 Nov; 12(11):10636-10664. PubMed ID: 30335963
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermia and smart drug delivery systems for solid tumor therapy.
Seynhaeve ALB; Amin M; Haemmerich D; van Rhoon GC; Ten Hagen TLM
Adv Drug Deliv Rev; 2020; 163-164():125-144. PubMed ID: 32092379
[TBL] [Abstract][Full Text] [Related]
37. Nanopreparations to overcome multidrug resistance in cancer.
Patel NR; Pattni BS; Abouzeid AH; Torchilin VP
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1748-62. PubMed ID: 23973912
[TBL] [Abstract][Full Text] [Related]
38. Engineering nanoparticles to tackle tumor barriers.
Li JX; Huang QY; Zhang JY; Du JZ
J Mater Chem B; 2020 Aug; 8(31):6686-6696. PubMed ID: 32579660
[TBL] [Abstract][Full Text] [Related]
39. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
40. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
